News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Daily News Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis L.A. McKeown August 09, 2022
News Daily News CMR Could Refine Early Management Decisions in Aortic Regurgitation L.A. McKeown July 27, 2022
News Daily News Black and Hispanic Patients Not Accessing High-Volume TEER Centers Michael O'Riordan July 19, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News TVT 2022 Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry Michael O'Riordan June 13, 2022
News Conference News TVT 2022 Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests Michael O'Riordan June 09, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2022 Shelley Wood June 01, 2022
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Better Durability With Self-Expanding TAVI? Clues From UK TAVI Shelley Wood May 18, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Opinion Editor's Corner EuroPCR 2022 EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect Shelley Wood May 12, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022